Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity. 2019

Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, 69 Pekarska, Lviv 79010, Ukraine; Department of Organic Chemistry and Pharmacy, Lesya Ukrainka Eastern European National University, Volya Avenue 13, 43025 Lutsk, Ukraine.

A series of novel 2-(5-aminomethylene-4-oxo-2-thioxothiazolidin-3-yl)-3-phenylpropionic acid ethyl esters has been synthesized. Target compounds were evaluated for their trypanocidal activity towards Trypanosoma brucei brucei and Trypanosoma brucei gambiense. Several hit-compounds (8, 10, 12) inhibited growth of the parasites at sub-micromolar concentrations (IC50 0.027-1.936 µM) and showed significant selectivity indices (SI = 108-1396.2) being non-toxic towards the human primary fibroblasts. The screening of anticancer activity in vitro within NCI DTP protocol allowed to identify active 2-(5-{[5-(2,4-dichlorobenzyl)-thiazol-2-ylamino]-methylene}-4-oxo-2-thioxothiazolidin-3-yl)-3-phenylpropionic acid ethyl ester 14 that demonstrated inhibition against all 59 human tumor cell lines with the average GI50 value of 2.57 μM. It was established that the activity type (antitrypanosomal or anticancer) as well as its level depends on the character of enamine fragment in the C5 position of thiazolidinone core.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014346 Trypanosoma brucei brucei A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina). Trypanosoma brucei,Trypanosoma brucei bruceus,Trypanosoma bruceus,brucei brucei, Trypanosoma,brucei, Trypanosoma brucei,bruceus, Trypanosoma,bruceus, Trypanosoma brucei
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
October 2014, European journal of medicinal chemistry,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2012, Archiv der Pharmazie,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2017, Chemico-biological interactions,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2022, Molecules (Basel, Switzerland),
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
May 2021, Molecular diversity,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
August 2022, Chemical biology & drug design,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2015, Current topics in medicinal chemistry,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2021, RSC advances,
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
January 2022, Medicinal chemistry (Shariqah (United Arab Emirates)),
Serhii Holota, and Anna Kryshchyshyn, and Halyna Derkach, and Yaroslava Trufin, and Inna Demchuk, and Andrzej Gzella, and Philippe Grellier, and Roman Lesyk
August 2009, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!